减少Intermacs患者分型评估者间变异性的算法
本研究开发了一种用于推导Intermacs患者分型(IPP)的算法,并邀请15名晚期心力衰竭专家对20个标准化临床案例进行两阶段IPP分配:第一阶段仅凭临床判断,第二阶段使用算法。结果显示部分案例的评估者间变异系数显著降低,算法可辅助临床决策及筛选临床试验患者。
要点
- 算法可复现经验丰富的专家对IPP的分配结果。
- 使用算法后部分案例的评估者间变异系数显著降低。
- 算法有望辅助临床决策及随机临床试验的患者筛选。
核心结论
- 算法分配的IPP与经验丰富的专家分配结果一致,可辅助临床决策和临床试验筛选。
研究设计与样本
- 开发算法后,邀请15名晚期心衰专家对20个标准化临床案例进行两阶段IPP分配,间隔超过3周并更换案例编号以减少偏倚。
主要发现
- 20个案例中,3个案例(14、16、17)的变异系数在两阶段间显著降低,1个案例(5)显著增加,其余无显著变化。
临床怎么用
- 算法可用于辅助临床医生进行IPP分配,并作为随机临床试验筛选患者的工具。
局限性
- 仅使用20个标准化案例,样本量有限。
- 部分案例变异系数未显著改善甚至增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intermacs Patient Profiles (IPP) are subjective assessments of patient acuity of illness assigned at the time of durable left ventricular assist device implantation (dLVAD). Previous studies have demonstrated provider variability with IPP assignment. We developed a novel algorithm to derive a patient's IPP acuity of illness to assist clinicians with IPP assignment. METHODS: Twenty standardized clinical vignettes were developed characterizing a patient's status at time of evaluation for dLVAD implantation. Vignettes included the full range of patient acuity of illness represented by IPPs. An algorithm to assign IPPs (1-7) was developed and tested among 15 advanced heart failure specialists invited to assign an IPP across two phases: Phase One (based solely on clinical judgment/experience) and Phase Two (using the algorithm). Phases One and Two were separated by > 3 weeks with vignette numbers changed to reduce risk of rater bias. Iinter-rater variability was tested using the Pitman-Morgan Test. We compared the coefficient of variation (CoV) among assessors for each patient vignette before and after using the standardized algorithm. RESULTS: Of 20 vignettes, 3 vignettes (14, 16, and 17) demonstrated significant reduction in CoV between Phase 1 & 2. One vignette (5) had a significant increase in CoV. The remaining vignettes demonstrated no significant changes in CoV between Phase 1 & 2. CONCLUSIONS: An algorithm assigning IPPs reproduces IPP assignments determined by heart failure specialists with previous experience assigning IPPs. The developed algorithm could be used to assist clinicians with patient decision-making as well as screening patients for randomized clinical trials.
引用
- Nassar K, Cabrera L, Likosky DS, et al. Algorithm to reduce inter-rater variability in assessment of intermacs patient profiles. J Heart Lung Transplant. 2026. PMID: 41534742. doi:10.1016/j.healun.2025.12.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。